Gray elected to Hereditary Disease Foundation’s Scientific Board

The University of Alabama at Birmingham’s Dr. Michelle Gray has been elected to be a member on the Scientific Board of the Hereditary Disease Foundation.
Written by: Fletcher Allen
Media contact: Bob Shepard

M.gray.2Michelle Gray, Ph.D.
(Photography: Lexi Coon)
Michelle Gray, Ph.D., associate professor in the Department of Neurology at the University of Alabama at Birmingham, has been elected to the Hereditary Disease Foundation’s Scientific Advisory Board.

Gray is the Dixon Scholar in Neuroscience in the Center for Neurodegeneration and Experimental Therapeutics, a scientist in the Comprehensive Neuroscience Center and the Evelyn F. McKnight Brain Institute, and co-director for the School of Medicine’s Summer in Biomedical Sciences Undergraduate Research Program. Her research focuses on the pathogenesis of Huntington’s disease with a specific interest in astrocytes, as well as cardiac abnormalities in Huntington’s disease and X-linked dystonia Parkinsonism. 

The HDF works to fund research to cure Huntington’s disease, a rare neurological illness that causes the progressive breakdown of nerve cells in the brain, which in turn, impairs a person’s mental and physical functions.